Vitamin K2 therapy for postmenopausal osteoporosis

Nutrients

Volumn 6, Issue 5, 2014, Pages 1971-1980

  Iwamoto, Jun ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone mineral density (BMD); Femoral neck; Postmenopausal women; Undercarboxylated osteocalcin

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ELCATONIN; ESTRADIOL; ETIDRONIC ACID; FARNOQUINONE; MENATETRENONE; OSTEOCALCIN;

BONE ATROPHY; BONE DENSITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE; HUMAN; INCIDENCE; OSTEOPOROSIS; PHASE 4 CLINICAL TRIAL (TOPIC); POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SPINE FRACTURE; ANALOGS AND DERIVATIVES; BLOOD; DRUG EFFECTS; FEMALE; FRACTURES, BONE; METABOLISM; OSTEOPOROSIS, POSTMENOPAUSAL; PHOTON ABSORPTIOMETRY; POSTMENOPAUSE;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; FEMALE; FRACTURES, BONE; HUMANS; INCIDENCE; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN K 2;

EID: 84900866576     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6051971     Document Type: Review

References (24)

1. Hauschka, P.V.; Lian, J.B.; Cole, D.E.; Gundberg, C.M. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol. Rev. 1989, 69, 990-1047.
2. 2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J. Bone Miner. Res. 1997, 12, 431-438.
3. Shearer, M.J. Vitamin K. Lancet 1995, 345, 229-234.
4. Vermeer, C.; Jie, K.S.; Knapen, M.H. Role of vitamin K in bone metabolism. Annu. Rev. Nutr. 1995, 15, 1-22.
5. Tsugawa, N.; Shiraki, M.; Kamao, M.; Kamao, M.; Ozaki, R.; Tanaka, K.; Okano, T. Usefulness of serum undercarboxylated osteocalcin measurement as a predictor for clinical fractures. Osteoporos. Jpn. 2010, 18, 254-256 (in Japanese).
6. Shiraki, M.; Yamazaki, Y.; Shiraki, Y.; Hosoi, T.; Tsugawa, N.; Okano, T. High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment. J. Bone Miner. Metab. 2010, 28, 578-584.
7. Orimo, H.; Fujita, T.; Onomura, T.; Inoue, T.; Kushida, K.; Shiraki, M. Clinical evaluation of soft capsule menatetrenone (Ea-0167) in the treatment of osteoporosis. Late Phase II Dose Study. J. New Rem. Clin. 1992, 41, 1249-1279 (in Japanese).
8. Orimo, H.; Nakamura, T.; Hosoi, T.; Iki, M.; Uenishi, K.; Endo, N.; Ohta, H.; Shiraki, M.; Sugimoto, T.; Suzuki, T.; et al. Japanese 2011 guidelines for prevention and treatment of osteoporosis-executive summary. Arch. Osteoporos. 2012, 7, 3-20.
9. Iwamoto, J.; Sato, Y.; Takeda, T.; Matsumoto, H. High-dose vitamin K supplementation reduces fracture incidence in postmenopausal women: A review of the literature. Nutr. Res. 2009, 29, 221-228.
10. 2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J. Bone Miner. Res. 2000, 15, 515-521.
11. Iwamoto, J.; Takeda, T.; Ichimura, S. Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: A comparison with the effect of etidronate. J. Orthop. Sci. 2001, 6, 487-492.
12. Ishida, Y.; Kawai, S. Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study. Am. J. Med. 2004, 117, 549-555.
13. Inoue, T.; Fujita, T.; Kishimoto, H.; Makino, T.; Nakamura, T.; Nakamura, T.; Sato, T.; Yamazaki, K. Randomized controlled study on the prevention of osteoporotic fractures (OF Study): A phase IV clinical study of 15-mg menatetrenone capsules. J. Bone Miner. Metab. 2009, 27, 66-75.
14. 2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis. J. Orthop. Sci. 2000, 5, 546-551.
15. 2 and vitamin D3 on bone mineral density and coagulofibrinolysis function in postmenopausal women. Maturitas 2002, 41, 211-221.
16. 2 treatment for postmenopausal osteoporosis in Indonesia. J. Obstet. Gynaecol. Res. 2006, 32, 230-234.
17. Jiang, Y.; Zhang, Z.L.; Zhang, Z.L.; Zhu, H.M.; Wu, Y.Y.; Cheng, Q.; Wu, F.L.; Xing, X.P.; Liu, J.L.; Yu, W.; et al. Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: A multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial. Clin. Interv. Aging 2014, 9, 121-127.
18. Shiraki, M.; Itabashi, A. Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: A randomized prospective study. J. Bone Miner. Metab. 2009, 27, 333-340.
19. 2 in postmenopausal women. J. Bone Miner. Metab. 2008, 26, 260-264.
20. Ducy, P.; Desbois, C.; Boyce, B.; Pinero, G.; Story, B.; Dunstan, C.; Smith, E.; Bonadio, J.; Goldstein, S.; Gundberg, C.; et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996, 382, 448-452.
21. 2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos. Int. 2007, 18, 963-972.
22. Nakagawa, K.; Hirota, Y.; Sawada, N.; Yuge, N.; Watanabe, M.; Uchino, Y.; Okuda, N.; Shimomura, Y.; Suhara, Y.; Okano, T. Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme. Nature 2010, 468, 117-121.
23. Cheung, A.M.; Tile, L.; Lee, Y.; Tomlinson, G.; Hawker, G.; Scher, J.; Hu, H.; Vieth, R.; Thompson, L.; Jamal, S.; et al. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): A randomized controlled trial. PLoS Med. 2008, 5, e196.
24. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ. Tech. Rep. Ser. 1994, 843, 1-129.